Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.00M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 7.00M | $ -1.17M | $ -3.04M | $ -2.24M | $ -542.00K |
| Operating Income | $ -139.71M | $ -132.28M | $ -123.54M | $ -113.73M | $ -58.76M |
| EBITDA | $ -139.71M | $ -131.11M | $ -122.22M | $ -112.82M | $ -58.22M |
| Net Income | $ -127.17M | $ -121.83M | $ -107.34M | $ -110.78M | $ -56.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 133.61M | $ 232.94M | $ 201.73M | $ 291.23M | $ 218.31M |
| Total Assets | $ 175.51M | $ 277.67M | $ 220.50M | $ 305.10M | $ 223.59M |
| Total Debt | $ 18.02M | $ 16.89M | $ 1.83M | $ 1.74M | $ 0.00 |
| Net Debt | $ 5.55M | $ -8.40M | $ -28.77M | $ -30.09M | $ -218.31M |
| Total Liabilities | $ 44.06M | $ 40.58M | $ 25.06M | $ 19.20M | $ 11.41M |
| Stockholders' Equity | $ 131.46M | $ 237.09M | $ 195.44M | $ 285.90M | $ 212.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -103.65M | $ -110.58M | $ -86.75M | $ -85.85M | $ -46.80M |
| Operating Cash Flow | $ -102.89M | $ -107.06M | $ -83.73M | $ -83.53M | $ -46.18M |
| Investing Cash Flow | $ 90.19M | $ -34.65M | $ 81.69M | $ -263.80M | $ -621.00K |
| Financing Cash Flow | $ -120.00K | $ 136.40M | $ 815.00K | $ 164.90M | $ 246.23M |